| |
|
| |
|
| |
Executive Team
|
| |
 |
Jatin Vimal
Jatin Vimal heads the Biotech business unit of Shasun Chemicals & Drugs Ltd. and has been working in the company for the past 7 years. He has a bachelors degree in Biotechnology and has pursued his Masters in Engineering Management from Duke University in the U.S. Prior to joining the biotech division, Jatin has been involved in managing various synthetic pharmaceutical projects & scaling-up challenging chemistries at the pilot plant scale. At the biotech unit, Jatin has been responsible for managing the technology development of various recombinant protein projects & bringing the quality systems in congruence with Shasun’s U.S. FDA-inspected facilities. |
 |
Kevin
Cook
Kevin Cook is the Operations director of Shasun Pharma Solutions Ltd. He has been with the UK unit since 1992. He is currently responsible for all SPSL Operations in the UK and is based at the Dudley UK Site.
He has 20 years experience in chemical and pharmaceutical manufacturing.
Previous managerial positions held include HSE, Supply Chain, Operations and New Product Introduction within the organisation and Various operational roles with Boots Pharmaceuticals.
He is a Chemistry and Chemical Engineering Graduate and MBA from Newcastle University |
 |
Dr. Michel Spagnol
Dr. Michel Spagnol completed the first part of his education in France, graduating as a chemical engineer from the ENSC in Mulhouse. In 1987, he moved to the US and completed his master and PhD at Stanford University under the supervision of Pr. Barry Trost.
After his graduation, he joined the Rhone–Poulenc group where he held several managerial positions in its central RD facility located in Lyon. The main focus of his work was directed towards the discovery and development of new catalysts for the synthesis of fine chemical.
During this time, Michel authored more than 50 patents and international publications and received numerous awards. In particular, he developed the first industrialization of Friedel Craft reactions using zeolithes and was honored by the green chemistry award.
Following a 2 years appointment as Business development director for the agrochemical market he returned to the field of R&D as vice president of innovation and technology for Rhodia’s fine chemical business.
In 2003, he moved to the US, as sales and marketing vice president for Rhodia’s pharmaceutical division. In 2006 following the divestment, he joined Shasun and heads the company’s sales and marketing worldwide organization for the CRAM business. |
 |
Suresh Balsubramani
Suresh Balsubramani, Chief Marketing Officer, is responsible for providing leadership and direction to the API business as well as providing innovative solutions and services to pharmaceutical customers globally. He is the external face of the organization.
A B.Tech in Chemical Engineering from the Indian Institute of Technology Madras, and an MBA from Southern Illinois University, Suresh has extensive experience in sales and marketing, product management and general management. Of note are his leadership positions, with Ciba Geigy, American Cyanamid and Wyeth Pharmaceuticals He has also served as Group Vice President ( Asia Pacific) for the agricultural chemicals business of BASF, based in Singapore. He has travelled to and struck deals in over 55 countries across the globe. |
|
 |
top |
| |
|
|
